Get the Stockscreener App
0.7259
8.11%
-0.0641
After Hours:
.72
-0.0059
-0.81%
Inspira Technologies Oxy B H N Ltd stock is traded at $0.7259, with a volume of 256.76K.
It is down -8.11% in the last 24 hours and up +29.62% over the past month.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
See More
Previous Close:
$0.79
Open:
$0.7622
24h Volume:
256.76K
Relative Volume:
0.52
Market Cap:
$18.60M
Revenue:
-
Net Income/Loss:
$-12.66M
P/E Ratio:
-0.6588
EPS:
-1.1018
Net Cash Flow:
-
1W Performance:
-0.01%
1M Performance:
+29.62%
6M Performance:
-37.96%
1Y Performance:
-62.77%
1-Day Range:
$0.71
$0.7677
1-Week Range:
$0.663
$0.844
52-Week Range:
$0.4026
$2.02
Inspira Technologies Oxy B H N Ltd Stock (IINN) Company Profile
Name
Inspira Technologies Oxy B H N Ltd
Sector
Industry
Phone
-
Address
-
Compare IINN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IINN
Inspira Technologies Oxy B H N Ltd
|
0.7259 | 18.60M | 0 | -12.66M | 0 | -1.1018 |
|
ABT
Abbott Laboratories
|
135.62 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
99.74 | 151.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
377.30 | 146.71B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.27 | 112.09B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.15 | 45.47B | 5.54B | 4.18B | 623.10M | 7.00 |
Inspira Technologies Oxy B H N Ltd Stock (IINN) Latest News
IINN’s Financial Health: Exploring Inspira Technologies Oxy B.H.N. Ltd’s Debt-to-Equity Ratio of 1.79 - investchronicle.com
Inspira Technologies’ ART100 Gains Traction in U.S. Hospitals - TipRanks
Inspira Technologies (IINN) Sees Boost in Commercial Interest Due to ART100 System | IINN Stock News - GuruFocus
Inspira Technologies Begins Commercial Adoption of FDA-Cleared ART100 System, Driving Global Interest in Life-Support Innovations - Nasdaq
Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions - The Manila Times
Inspira's ART100 Life Support System Deployed at Top US Hospitals | IINN Stock News - Stock Titan
Citadel Advisors LLC Has $88,000 Stake in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) - Defense World
Inspira Technologies boosts production of FDA-cleared system By Investing.com - Investing.com South Africa
CORRECTIONInspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority - The Manila Times
Inspira Technologies (IINN) Boosts Production for Anticipated Eu - GuruFocus
Inspira Technologies boosts production of FDA-cleared system - Investing.com
Inspira Technologies Boosts ART100 Production Amid European Negotiations - TipRanks
Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority - The Manila Times
Inspira Technologies Scales Up Production of INSPIRA ART100 System Amid European Procurement Negotiations - Nasdaq
Research Analysts Offer Predictions for IINN FY2025 Earnings - Defense World
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) Raised to Strong-Buy at Litchfield Hills Research - Defense World
Litchfield Hills Initiates Coverage of Inspira Technologies Oxy B.H.N. (IINN) with Buy Recommendation - Nasdaq
Inspira Technologies Oxy (IINN) Coverage Initiated with 'Buy' Rating | IINN Stock News - GuruFocus
Inspira Technologies (IINN) Receives Buy Rating from Analyst | I - GuruFocus
Inspira Technologies Receives $2 Price Target And Buy Rating: Everything You Need To Know - MENAFN.com
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) Trading Up 9.3% – Still a Buy? - Defense World
Inspira Technologies Announces Shareholder Meeting to Address Nasdaq Compliance - TipRanks
Inspira Technologies ramps up ART100 system commercialization By Investing.com - Investing.com South Africa
Inspira (IINN) Strategizes for Enhanced U.S. Commercialization o - GuruFocus
Inspira Technologies Begins Rollout of ART100 System; Shares Rise - marketscreener.com
Inspira Technologies Initiates Global Commercial Rollout of FDA -Cleared ART100 System - marketscreener.com
Inspira Technologies ramps up ART100 system commercialization - Investing.com Australia
Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System - The Manila Times
Inspira Technologies Announces Strategic Shift to Accelerate Commercialization of INSPIRA ART100 System - Nasdaq
Inspira's FDA-Cleared Alternative to Mechanical Ventilation Begins Worldwide Launch After US Success - Stock Titan
Inspira Technologies Restructures Executive Team for Strategic Alignment - TipRanks
Inspira Technologies restructures executive team By Investing.com - Investing.com South Africa
Inspira Technologies (IINN) Restructures Leadership for Strategi - GuruFocus
Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives - The Manila Times
Inspira Technologies restructures executive team - Investing.com
Inspira Technologies Co-Founder Exits President Role as Company Pivots Strategy - Stock Titan
Inspira Technologies stock hits 52-week low at $0.46 By Investing.com - Investing.com South Africa
Inspira Technologies stock hits 52-week low at $0.46 - Investing.com
Inspira Technologies Shareholders Approve Key Agenda Items at May 2025 Meeting - TipRanks
Renaissance Technologies LLC Boosts Stock Position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) - Defense World
Inspira’s ART100 system set for transplant validation in Israel By Investing.com - Investing.com South Africa
Stock Performance Spotlight: Inspira Technologies Oxy B.H.N. Ltd (IINN) Ends the Day at 0.58, Down by -3.78 - DWinneX
Inspira’s ART100 System Gains Approval for Organ Transplant Use in Israel - TipRanks
Inspira’s ART100 system set for transplant validation in Israel - Investing.com
INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients - The Manila Times
Inspira Technologies' INSPIRA ART100 Approved for Clinical Validation in Organ Transplant Procedures by Israel's Largest Healthcare Provider - Nasdaq
Inspira Technologies Oxy B H N Ltd Stock (IINN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.68%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):